- Category: Products
Products
Focus Vitamins launches PF artificial tears for dry eye
Manufactured by cGMP- and NSF-certified suppliers, Focus Tears PF Eye Drops are formulated with CMC sodium 0.5% to offer temporary ocular relief.Products
WAVE Lens Designer Software integrates with Topcon MYAH
Integration enables direct import of corneal topography data into custom lens platform, streamlining the specialty contact lens design workflow.Products
Dr. Reddy's olopatadine HCl 0.7% launches as first-to-market generic
The OTC eye drop is a bioequivalent to Alcon’s Once Daily Extra Strength, with ocular allergy relief lasting 24 hours.Products
FDA clears Rayner's Sophi phacemulsification system
First battery-powered, wireless phaco system features triple pump fluidics for more control of anterior chamber stability during cataract surgery.Products
FDA approves Gland Pharma's OTC Extra Strength Pataday generic
Olopatadine HCl ophthalmic solution 0.7% is indicated to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander for 24 hours.Products
Euclid Vision launches new SiHy daily disposable lens for myopia
The Be Free Day soft lens for pediatric myopes features BHVI's proprietary dual action, multistep optical design technology.Products
FDA clears first EDOF contact lens for presbyopia
U.S. approval is first for a daily disposable, extended-depth-of-field lens requiring no patient cognitive adaptation period for presbyopia correction.Products
FDA approves Formycon and Bioeq's Lucentis biosimilar
Nufymco (ranibizumab-leyk) marks the companies’ second ranibizumab biosimilar cleared in the U.S. to treat five retinal indications.Products
Your rundown: 2025 approvals and launches
Take a trip down memory lane for a look at this year’s latest additions to the ophthalmic space.Products
Rinsada expands irrigating eyelid retractor distribution to Canada
Already FDA-cleared in the U.S., the medical device is now registered by Health Canada and only available through online retailer Eye Drop Shop.Products
FDA approves Alembic Pharma's loteprednol etabonate and tobramycin ophthalmic suspension
Generic of Bausch + Lomb’s ZYLET for steroid-responsive inflammatory ocular conditions qualifies for 6 months of market exclusivity once commercially launched.Products
Scope's OPTASE HYLO Forte Dry Eye Drops offer long-lasting symptom relief
Clinical experts share OD-MD insights into the advanced artificial tears’ hydrating PF formulation with active glycerin and hyaluronic acid.Products
Amneal receives FDA approval for Restasis generic
Generic version of Allergan’s cyclosporine ophthalmic emulsion 0.05% eye drop for dry eye is the second to receive U.S. regulatory clearance.Products
Evoq launches FDA-registered dark adaptation testing device for IRDs
The Twilight is a wearable and smartphone-based diagnostic tool for at-home, remote monitoring of retinal health and early retinal disease detection.Products
FDA approves new EYLEA HD indication, expanded dosing intervals
Intravitreally-administered 2 mg aflibercept therapeutic is now cleared for macular edema following retinal vein occlusion.Products
FDA clears Topcon's OMNIA auto kerato-refracto tonometer
Now commercially available, the fully automated ophthalmic device offers refraction, keratometry, tonometry, and pachymetry.Products
OCULUS Smartfield Perimeter launches into space
Compact and portable visual field analyzer device is aiding in ISS research on spaceflight-associated neuro-ocular syndrome (SANS).Products
myze launches daily lid-and-lash Manuka honey-based cleanser
The Foam is formulated with manuka honey, offering antimicrobial and anti-inflammatory effects for long-term ocular health.Products
Barti launches new AI guidelines for EHR
Practice management platform now offers a built-in tool that instantly references and applies evidence-based recommendations directly within patient charts.Products